Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

American Journal of Human Genetics

Volumn 68, Issue 3, 2001, Pages 700-710

  Risch, Harvey A ^a   McLaughlin, John R ^b,c   Cole, David E C ^d   Rosen, Barry ^e   Bradley, Linda ^e   Kwan, Elaine ^f   Jack, Elaine ^f   Vesprini, Danny J ^f   Kuperstein, Graciela ^f   Abrahamson, John L A ^f   Fan, Isabel ^f   Wong, Betty ^d   Narod, Steven A ^c,f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Public Health Department   (Canada)

^d Departments of Clinical Biochemistry   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOCYTE; LYMPHOMA; MAJOR CLINICAL STUDY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER;

TRIXIS;

EID: 0035098503     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/318787     Document Type: Article

References (40)

1. Risk models for familial ovarian and breast cancer
2. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
3. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations
4. Cancer risks in BRCA2 mutation carriers
5. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
6. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
7. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer
8. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
9. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
10. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
11. Germline BRCA1 alterations in a population-based series of ovarian cancer cases
12. Tumour biological features of BRCA1-induced breast and ovarian cancer
13. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations
14. A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes
15. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
16. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
17. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation
18. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
19. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls
20. Genetic heterogeneity of breast-ovarian cancer revisited
21. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families
22. An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation?
23. Differences in risk factors for epithelial ovarian cancer by histologic type: Results of a case-control study
24. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing
25. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening
26. BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing
27. BRCA1 and BRCA2 have a limited role in familial prostate cancer
28. Contribution of BRCA1 mutations to ovarian cancer
29. The genetic epidemiology of early-onset epithelial ovarian cancer: A population-based study
30. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
31. Mutation analysis of the BRCA1 gene in ovarian cancers
32. Mutations of the BRCA2 gene in ovarian carcinomas
33. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
34. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families
35. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
36. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing
37. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary
38. The kin-cohort study for estimating penetrance
39. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer